Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2013 16:00 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Staffing Transition

PALO ALTO, Calif., Dec. 11, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) today announced that David S. Moore, its chief business officer, will be leaving Ocera to pursue other...
November 26, 2013 16:00 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at Piper Jaffrey Healthcare Conference

PALO ALTO, Calif., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
November 13, 2013 17:00 ET | Source: Ocera Therapeutics, Inc.

Ocera Reports Third Quarter Business Update and Financial Results

PALO ALTO, Calif., Nov. 13, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a biopharmaceutical company focused on innovative therapeutics for orphan liver disease, announced today...
November 06, 2013 08:30 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces $28 Million Private Placement

SAN DIEGO, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a biopharmaceutical company focused on innovative therapeutics for orphan liver disease, announced today that it has...
September 25, 2013 05:10 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at BIO Investor on October 8, 2013

SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that...
September 17, 2013 16:20 ET | Source: Ocera Therapeutics, Inc.

Ocera Announces Post-Merger Closure of Quebec Research Site

SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focusing on acute and chronic orphan liver diseases, today announced a...
September 03, 2013 05:10 ET | Source: Ocera Therapeutics, Inc.

Jeryl L. Hilleman Joins Ocera Therapeutics as Chief Financial Officer

SAN DIEGO, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Jeryl...
August 13, 2013 17:52 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Second Quarter 2013 Financial Results

SAN DIEGO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera" or the "Company") (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on the development and...
July 26, 2013 05:10 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Report Second Quarter 2013 Financial Results

SAN DIEGO, July 26, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) today announced that the Company will report second quarter 2013 financial results after the close of the market on...
July 15, 2013 12:04 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Completion of Merger With Tranzyme

SAN DIEGO, July 15, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera"), a clinical stage biopharmaceutical company developing novel therapeutics for orphan liver diseases, and Tranzyme, Inc....

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right